Multiple Sclerosis

’All the data we have right now suggests alcohol causes more harm than cannabis. That’s the hypothesis.’

A long-awaited study into Paolo Zamboni’s treatment yields disappointment for most sufferers—yet hope of relief for a few

Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions

The stem cell treatment for MS greeted as a "cure" is a breakthrough for five per cent of people with MS. What about the other 95 per cent?

Anne Kingston on how the criticism levelled at Kirsty Duncan over a controversial MS treatment is surprisingly unscientific

Two new studies suggest a potential game-changer in how scientists understand of the brain, which could advance research on MS and Alzheimer’s

The cheeky rebranding of multiple sclerosis in Canada raises the fair question: why are rates so high here?

Anne Kingston on the MS research that captured headlines in 2013

Last week’s shut-down of the Albany, NY clinical trial investigating CCSVI treatment due to lack of patient enrollment is a big...

Anne Kingston explains why we’ve reached the WTF moment in CCSVI research